Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

H Rader; H Grunze; F Ohl; ME Keck; [No Value] Giegling; D Rujescu; Frauke Ohl

Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

H Rader, H Grunze, F Ohl, ME Keck, [No Value] Giegling, D Rujescu, Frauke Ohl

Research output: Contribution to journal › Meeting Abstract › Other research output

Original language	English
Pages (from-to)	254-254
Number of pages	1
Journal	Pharmacopsychiatry
Volume	36
Issue number	5
Publication status	Published - Sept 2003
Event	23rd Symposium of the Arbeitsgemeinschaft-Neuropsychopharmakologie-und-Pharmakopsychiatrie (AGNP) - MUNICH, Germany Duration: 8 Oct 2003 → 10 Oct 2003

Cite this

@article{8a8f44f75ca34d48b3e2610196ee1142,

title = "Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis",

author = "H Rader and H Grunze and F Ohl and ME Keck and Giegling, {[No Value]} and D Rujescu and Frauke Ohl",

year = "2003",

month = sep,

language = "English",

volume = "36",

pages = "254--254",

journal = "Pharmacopsychiatry",

issn = "0176-3679",

publisher = "Georg Thieme Verlag",

number = "5",

note = "23rd Symposium of the Arbeitsgemeinschaft-Neuropsychopharmakologie-und-Pharmakopsychiatrie (AGNP) ; Conference date: 08-10-2003 Through 10-10-2003",

}

TY - JOUR

T1 - Effects of chronic MK-801 treatment on the relative mRNA expression of NMDA receptor subunits and splice variants in a pharmacological model for psychosis

AU - Rader, H

AU - Grunze, H

AU - Ohl, F

AU - Keck, ME

AU - Giegling, [No Value]

AU - Rujescu, D

AU - Ohl, Frauke

PY - 2003/9

Y1 - 2003/9

M3 - Meeting Abstract

SN - 0176-3679

VL - 36

SP - 254

EP - 254

JO - Pharmacopsychiatry

JF - Pharmacopsychiatry

IS - 5

T2 - 23rd Symposium of the Arbeitsgemeinschaft-Neuropsychopharmakologie-und-Pharmakopsychiatrie (AGNP)

Y2 - 8 October 2003 through 10 October 2003

ER -